Leaders say they want innovation, yet reward speed and predictability. Learning from nature shows how curiosity and culture ...

The path to AI success starts with a single, well-chosen use case: one that is bold enough to inspire, urgent enough to ...

By 2030, personal AI agents will mediate virtually all consumer interactions. These agents will do more than recommend ...

AI product manager, Jyothi Nookula, explores how organizations can democratize AI product skills to foster innovation across ...

Regulatory changes from the EPA have catalyzed significant innovations in gas chromatography, enhancing analytical ...

AI isn’t stuck because of tech — it’s stuck because of fear. This guide shows CIOs how to turn stalled pilots into real ...

Generative AI (GenAI) has moved rapidly from experimentation into day-to-day use across many organizations. Over the past ...

What is chain-hopping? Know why moving funds across incompatible L1 blockchains creates blind spots for AML tools and ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

Like many companies, Ernst & Young and Lumen have been working to bring AI tools and services into their respective operations. But they’ve taken very different approaches to find success.

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- The global apparel industry is undergoing a profound ...

CERES Division Positioning -- Growing demand for advanced payment integrity services as regulatory scrutiny and payer financial pressures increase; early integration benefits from the recent ...